AboutAaron Gerber, MD, MBA

Aaron Gerber, MD, MBAPresident

As Sg2 president, Aaron provides overall leadership and strategic direction, guiding Sg2 to further expand its suite of analytics-based health care intelligence to help hospitals and health systems drive growth and performance across the continuum of care.

A values-driven leader with an entrepreneurial spirit, Aaron has 18 years of experience working with a broad set of health care organizations as a senior executive, management consultant and private equity investor.

Prior to joining Sg2, Aaron was a partner in the Health and Life Sciences Practice at Oliver Wyman. In that role, he was responsible for selling and delivering strategic consulting engagements to leading health care providers. Aaron was focused on the design of business and clinical models to effectively meet the demands of consumer-centric, value-based care. His additional areas of expertise included growth strategy, strategic partnerships, new business creation and development, population health management, physician alignment, consumer experience, and retail health care. At Oliver Wyman, Aaron led a strategic initiative to help drive collaboration across the operating companies of Oliver Wyman’s parent, Marsh and McLennan Companies.

Prior to his work with Oliver Wyman, Aaron was the SVP of Strategy and Business Development for Vanguard Health Chicago, a $700 million for-profit health system with 4 acute care hospitals and a wide variety of ambulatory assets. As SVP, he was responsible for strategy, business development, marketing, physician alignment and service line development for the organization.

Earlier in his career, Aaron was the cofounder and chief executive officer of a company in the executive health and wellness services space that was sold to Northwestern Memorial Hospital.

Aaron received his medical degree and a master’s degree in business administration from Northwestern University.

"Analytics and expertise to help you understand market dynamics and capitalize opportunities for growth."

As of February 11, 2016, Vizient, Inc. has completed its purchase of MedAssets Sg2 and spend and clinical resource management segments from Pamplona Capital Management, LLC. MedAssets revenue cycle business will continue to operate as a wholly-owned subsidiary of Pamplona Capital Management LLP.

Follow Sg2 on Twitter Connect with Sg2 on LinkedIn Watch Sg2 on YouTube